Maharashtra continues to face acute shortage of two key medicines being used to treat coronavirus in India - Remdesivir and Tocilizumab injections, both approved by the US Food and Drug Authority for the treatment of COVID-19. With this, relatives of patients getting treatment in private hospitals of Mumbai, Thane and Pune have been left to fend for themselves. Experts and caregivers cautioned this state of affairs could have implications on the mortality rate in these cities, all of which are throwing up high number of coronaviruses cases every day.
